New patent for Esperion Theraps drug NEXLETOL

   April 3, 2021    Comments Off on New patent for Esperion Theraps drug NEXLETOL    Posted in: Patent Added

Annual Drug Patent Expirations for NEXLETOL Nexletol is a drug marketed by Esperion Theraps Inc and is included in one NDA. There are five patents protecting this drug. NEXLETOL drug…

The post New patent for Esperion Theraps drug NEXLETOL appeared first on DrugPatentWatch - Make Better Decisions.

  

Comments are closed.

Biotechblog